Novel mechanisms of MITF regulation identified in a mouse suppressor screen

Hong Nhung Vu1, Matti Már Valdimarsson2, Sara Sigurbjörnsdóttir1

  • 1Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland.

EMBO Reports
|August 21, 2024
PubMed

Insights

A genetic screen identified a mutation in the Microphthalmia-associated Transcription Factor (MITF) that enhances nuclear localization and stability. This discovery reveals a novel mechanism for genetic suppression, explaining how mutations can lead to normal phenotypes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Microphthalmia-associated Transcription Factor (MITF) is crucial for melanocyte development and acts as an oncogene.
  • Understanding MITF regulation is key to comprehending pigmentation and melanoma.
  • Genetic screens are powerful tools for identifying novel regulatory mechanisms.

Purpose of the Study:

  • To identify genetic suppressors of Mitf-associated pigmentation defects.
  • To elucidate the molecular mechanisms underlying MITF regulation and its impact on phenotype.
  • To investigate the interplay between MITF mutations, SUMOylation, and phosphorylation.

Main Methods:

  • Genetic screening in mice to identify suppressors of Mitf pigmentation phenotype.
  • Characterization of an intragenic Mitf mutation affecting the K316 SUMOylation site.
  • Biochemical and biophysical analyses, including smFRET, to study protein interactions and localization.
  • Analysis of melanoma-associated mutations in MITF.

Main Results:

  • An intragenic Mitf mutation was identified, leading to MITF truncation at the K316 SUMOylation site and loss of the C-terminal intrinsically disordered region (IDR).
  • The truncated MITF protein exhibits increased nuclear localization and altered stability, while retaining DNA-binding ability.
  • The mutant MITF dimer can stabilize wild-type and mutant MITF partners in the nucleus, ensuring nuclear MITF supply.
  • Interactions between K316 SUMOylation and S409 phosphorylation sites across monomers were observed, explaining the phenotypic effects.
  • The melanoma-associated E318K mutation impacts K316 SUMOylation and interacts with S409 phosphorylation.

Conclusions:

  • MITF SUMOylation at K316 and phosphorylation at S409 are critical regulatory sites influencing nuclear localization and stability through conformational changes.
  • A novel mechanism of genetic suppression involving MITF truncation and altered protein-protein interactions was discovered.
  • Deleterious mutations can paradoxically lead to normal phenotypes through compensatory regulatory mechanisms.